Fojo AT - Search Results

1

Novel Tumor Growth Rate Analysis in the Randomized CLARINET Study Establishes the Efficacy of Lanreotide Depot/Autogel 120 mg with Prolonged Administration in Indolent Neuroendocrine Tumors.

Dromain C, Loaiza-Bonilla A, Mirakhur B, Beveridge TJR, Fojo AT. Dromain C, et al. Among authors: fojo at. Oncologist. 2021 Apr;26(4):e632-e638. doi: 10.1002/onco.13669. Epub 2021 Feb 1. Oncologist. 2021. PMID: 33393112 Free PMC article.

2

Clinical trial results: a clinical trial bazaar!

Fojo AT, Bates SE. Fojo AT, et al. Oncologist. 2014 Apr;19(4):313-4. doi: 10.1634/theoncologist.2014-0091. Epub 2014 Mar 25. Oncologist. 2014. PMID: 24668329 Free PMC article.

3

Clinical reversal of multidrug resistance.

Bates SE, Wilson WH, Fojo AT, Alvarez M, Zhan Z, Regis J, Robey R, Hose C, Monks A, Kang YK, Chabner B. Bates SE, et al. Among authors: fojo at. Stem Cells. 1996 Jan;14(1):56-63. doi: 10.1002/stem.140056. Stem Cells. 1996. PMID: 8820952 Review.

4

Progress and Opportunities to Advance Clinical Cancer Therapeutics Using Tumor Dynamic Models.

Bruno R, Bottino D, de Alwis DP, Fojo AT, Guedj J, Liu C, Swanson KR, Zheng J, Zheng Y, Jin JY. Bruno R, et al. Among authors: fojo at. Clin Cancer Res. 2020 Apr 15;26(8):1787-1795. doi: 10.1158/1078-0432.CCR-19-0287. Epub 2019 Dec 23. Clin Cancer Res. 2020. PMID: 31871299 Free PMC article. Review.

5

Identification of Non-Small Cell Lung Cancer Sensitive to Systemic Cancer Therapies Using Radiomics.

Dercle L, Fronheiser M, Lu L, Du S, Hayes W, Leung DK, Roy A, Wilkerson J, Guo P, Fojo AT, Schwartz LH, Zhao B. Dercle L, et al. Among authors: fojo at. Clin Cancer Res. 2020 May 1;26(9):2151-2162. doi: 10.1158/1078-0432.CCR-19-2942. Epub 2020 Mar 20. Clin Cancer Res. 2020. PMID: 32198149 Free PMC article.

6

Acetyl-L-carnitine and prevention of chemotherapy-induced peripheral neuropathy: can anything work?

Burotto M, Fojo AT. Burotto M, et al. Among authors: fojo at. Oncologist. 2013;18(11):1151-2. doi: 10.1634/theoncologist.2013-0385. Oncologist. 2013. PMID: 24217999 Free PMC article. No abstract available.

7

Clinical trial results: Sharing results, speeding discoveries.

Fojo AT, Bates SE, Chabner BA. Fojo AT, et al. Oncologist. 2013;18(7):779. doi: 10.1634/theoncologist.2013-0247. Oncologist. 2013. PMID: 23882019 Free PMC article. No abstract available.

8

Phase 0 clinical trials: recommendations from the Task Force on Methodology for the Development of Innovative Cancer Therapies.

Kummar S, Doroshow JH, Tomaszewski JE, Calvert AH, Lobbezoo M, Giaccone G; Task Force on Methodology for the Development of Innovative Cancer Therapies (MDICT). Kummar S, et al. Eur J Cancer. 2009 Mar;45(5):741-6. doi: 10.1016/j.ejca.2008.10.024. Epub 2008 Dec 16. Eur J Cancer. 2009. PMID: 19091546 Free PMC article. Review.

9

Targeting MDR in breast and lung cancer: discriminating its potential importance from the failure of drug resistance reversal studies.

Amiri-Kordestani L, Basseville A, Kurdziel K, Fojo AT, Bates SE. Amiri-Kordestani L, et al. Among authors: fojo at. Drug Resist Updat. 2012 Feb-Apr;15(1-2):50-61. doi: 10.1016/j.drup.2012.02.002. Epub 2012 Mar 29. Drug Resist Updat. 2012. PMID: 22464282 Free PMC article. Review.

10

Reversal of multidrug resistance.

Bates SE, Zhan Z, Dickstein B, Lee JS, Scala S, Fojo AT, Paull K, Wilson W. Bates SE, et al. Among authors: fojo at. Prog Clin Biol Res. 1994;389:33-7. Prog Clin Biol Res. 1994. PMID: 7700913 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

148 results

Search Page